Search results

3 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit
Chapel Hill - In a clinical trial of an experimental drug to treat thyroid cancer, UNC and six other institutions report the first evidence in this tumor that targeting therapy to an oncogene documented to be present in the patient receiving therapy may be associated with clinical benefit.
Located in News / 2012 News
Family House Diaries: Salie Babilonia - How “The Look” Speaks Volumes
A Dare County, N.C., wife and mother of three keeps her spunky, positive spirit intact during treatment for thyroid cancer, buoying herself, her family and her medical team on the journey.
Located in News
Rising thyroid cancer rate linked to more testing, UNC-led study finds
A dramatic increase in the thyroid cancer rate across the last 30 years has researchers asking whether the disease’s incidence is truly on the rise, or if improved detection methods are behind the trend.
Located in News